Specialty: Mental Health, Primary sub-specialty: Anxiety - stress
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 18 years or older 2. Currently employed by an NHS trust in Kent, Surrey or Sussex 3. Work in a role that involves direct contact with patients for at least one day per week . 4. Currently in work (i.e. are not on long term sickness absence) 5. Not currently undertaking and/ or are willing to refrain from engaging in any other psychological intervention during the 125-day course of the study 6. Self-reported sufficient English language ability to read and listen to the MBSH intervention materials 7. Regular personal access to an Apple or Android smartphone/ tablet or to a computer with internet access
Exclusion criteria
Exclusion criteria: Not meeting inclusion criteria.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Stress is measured using the Depression, Anxiety and Stress Scale (DASS – 21; Lovibond & Lovinbond, 1995) at baseline and 125 days. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Depression is measured using the DASS-21 at baseline, day 35 and 125 2. Anxiety is measured using the DASS-21 at baseline, day 35 and 125 3. Mindfulness is measured using the Five-Facet Mindfulness Questionnaire – Fifteen Items (FFMQ-15; Baer et al., 2008; Gu et al., 2016) at baseline, day 35 and 125 4. Self-compassion is measured using the Self-Compassion Scale – Short Form (SCS-SF; Raes, Pommier, Neff, & Gucht, 2011) at baseline, day 35 and 125 5. Well-being is measured using the Short Warwick-Edinburgh Mental Well-being Scale (SWEMWS; NHS Health Scotland, University of Warwick & University of Edinburgh, 2007) at baseline, day 35 and 125 6. Burn-out is measured using the Maslach Burnout Inventory (MBI; Maslach & Jackson, 1986) at baseline, day 35 and 125 7. Compassion-for-others is measured using the Compassionate Love For Humanity Scale (CLS; Sprecher, & Fehr, 2005) at baseline, day 35 and 125 8. Rumination is measured using the Ruminative Response Scale (RRS; Nolen-Hoeksema & Morro, 1991; Treynor, Gonzalez, & Nolen-Hoeksema, 2003) at baseline, day 35 and 125 9. Worry is measured using the Penn State Worry Questionarre (PSWQ; Mayer, Miller, Metzger, & Borkovek, 1990) at baseline, day 35 and 125 10. Sickness absence concerning the 3 months prior to the intervention, and the 3 months following the initial 30-day intervention period is measured using a non-validated questionnaire at baseline and 125-days, and where consent has been obtained, via objective sickness absence data provided by NHS Human Resources departments, after trial completion. 11. Adherence to and engagement with both interventions is measured using non-validated questionnaires and objective usage data provided by Headspace for participants assigned to the Headspace condition, at day 35 and 125 12. Beliefs about engaging with Headspace is measured using a non-validated questionnaire at baseline and 35 days 13. Expectations of Headspace and Moodzone is measured using non-validated questionnai | — |
Countries
England, United Kingdom